Gottlieb Ja

511 total citations
12 papers, 435 citations indexed

About

Gottlieb Ja is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gottlieb Ja has authored 12 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gottlieb Ja's work include Cancer therapeutics and mechanisms (2 papers), Melanoma and MAPK Pathways (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). Gottlieb Ja is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Melanoma and MAPK Pathways (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). Gottlieb Ja collaborates with scholars based in United States. Gottlieb Ja's co-authors include Block Jb, Oliverio Vt, Guarino Am, Benjamin Drewinko, Burgess Ma, Emil Frei, Livingston Rb, Bodey Gp, Robert B. Livingston and Kun Lü and has published in prestigious journals such as PubMed.

In The Last Decade

Gottlieb Ja

12 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gottlieb Ja United States 8 356 284 68 58 36 12 435
Oliverio Vt 8 258 0.7× 235 0.8× 39 0.6× 41 0.7× 30 0.8× 9 441
M. Claire Walker United Kingdom 10 391 1.1× 229 0.8× 22 0.3× 31 0.5× 16 0.4× 12 538
G A Hofmann United States 7 600 1.7× 336 1.2× 147 2.2× 60 1.0× 27 0.8× 10 657
Masami Bungo Japan 7 264 0.7× 242 0.9× 39 0.6× 11 0.2× 14 0.4× 10 396
K W Kohn United States 7 325 0.9× 234 0.8× 26 0.4× 12 0.2× 15 0.4× 9 465
Todd D. Shenkenberg United States 7 123 0.3× 108 0.4× 26 0.4× 15 0.3× 14 0.4× 9 333
Di Marco A Italy 13 146 0.4× 214 0.8× 19 0.3× 9 0.2× 13 0.4× 28 355
Brenda J. Foster United States 12 293 0.8× 143 0.5× 14 0.2× 13 0.2× 33 0.9× 15 476
William G. Chapman United States 9 319 0.9× 375 1.3× 9 0.1× 9 0.2× 14 0.4× 9 630
Helen Chin-Sinex United States 13 342 1.0× 160 0.6× 14 0.2× 9 0.2× 12 0.3× 26 544

Countries citing papers authored by Gottlieb Ja

Since Specialization
Citations

This map shows the geographic impact of Gottlieb Ja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gottlieb Ja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gottlieb Ja more than expected).

Fields of papers citing papers by Gottlieb Ja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gottlieb Ja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gottlieb Ja. The network helps show where Gottlieb Ja may publish in the future.

Co-authorship network of co-authors of Gottlieb Ja

This figure shows the co-authorship network connecting the top 25 collaborators of Gottlieb Ja. A scholar is included among the top collaborators of Gottlieb Ja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gottlieb Ja. Gottlieb Ja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ma, Burgess, et al.. (1977). Phase I-II evaluation of cyclocytidine.. PubMed. 61(3). 437–43. 8 indexed citations
2.
Rb, Livingston, et al.. (1976). Sequential combination chemotherapy for advanced, recurrent, squamous carcinoma of the head and neck.. PubMed. 60(1). 103–5. 12 indexed citations
3.
Drewinko, Benjamin & Gottlieb Ja. (1976). Action of Cis-dichlorodiammineplatinum(II) (NSC-119875) at ehe cellular level.. PubMed. 59(3). 665–73. 21 indexed citations
4.
Ja, Gottlieb. (1974). Proceedings: Combination chemotherapy for metastatic sarcoma.. PubMed. 58(2). 265–70. 7 indexed citations
5.
Lü, Kun, et al.. (1974). Disposition and metabolism of thiopurines. II. Arabinosyl-6-mercaptopurine and ribosyl-6-mercaptopurine.. PubMed. 1(4). 645–52. 6 indexed citations
6.
Gp, Bodey, Gottlieb Ja, Robert B. Livingston, & Emil Frei. (1973). New agents and combinations in the treatment of bronchogenic carcinoma.. PubMed. 4(2). 227–9. 8 indexed citations
7.
Ja, Gottlieb. (1973). Combination chemotherapy: rationale for schedule selection and use of agents with independent toxicities in phase I and II clinical trials.. PubMed. 5(3). 1185–9. 1 indexed citations
8.
Ja, Gottlieb, et al.. (1972). Proceedings: Recent progress in the chemotherapy of primary tumors of bone.. PubMed. 7. 959–62. 1 indexed citations
9.
Ja, Gottlieb, et al.. (1972). Treatment of malignant melanoma with camptothecin (NSC-100880).. PubMed. 56(1). 103–5. 133 indexed citations
10.
Ja, Gottlieb, et al.. (1971). Dose-schedule studies with hydroxyurea (NSC-32065) in malignant melanoma.. PubMed. 55(3). 277–80. 7 indexed citations
11.
Ja, Gottlieb, et al.. (1970). Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880).. PubMed. 54(6). 461–70. 227 indexed citations
12.
Ja, Gottlieb, et al.. (1970). An evaluation of large intermittent intravenous doses of cyclophosphamide (NSC-26271) in the treatment of metastatic malignant melanoma.. PubMed. 54(5). 365–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026